chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slurred speech, double vision, loss of balance, pain in both legs, nausea, fever,
Area is slightly warm to touch. 2 inch red circle around injection site.  A slight hardness where shot was given.  A small amount of discomfort.
Patient was too old to receive the first dose of oral rotateq. No noted adverse symptoms at time of error.
blood pressure dropped to 60/40; This is a Spontaneous report from a contactable consumer. This consumer reported for a female patient (Daughter). This is the second case out of the 2 cases A female patient of unspecified age had received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose  number unknown via an unspecified route of administration on unknown date  as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient had experienced Blood pressure dropped to 60/40 after the administration of vaccine. It was also reported that because of side -effect patient had to require an ambulance and hospitalized. On an unspecified date, the patient underwent lab test and procedures which had included blood pressure measurement and diagnosed as having 60/40 blood pressure. The outcome of the event was unknown.  Information about lot/batch number cannot be obtained. No further information expected.
Fever, fever again,it was a very low fever; Chills, chills again; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), SYMPTOM RECURRENCE (fever again), PYREXIA (it was a very low fever) and SYMPTOM RECURRENCE (chills again) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history not  included .  relevant concomitant products usage were not reported by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.  On 20-Mar-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 24-Mar-2021, the patient experienced SYMPTOM RECURRENCE (fever again), PYREXIA (it was a very low fever) and SYMPTOM RECURRENCE (chills again).  On 21-Mar-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, SYMPTOM RECURRENCE (fever again), PYREXIA (it was a very low fever) and SYMPTOM RECURRENCE (chills again) outcome was unknown.        The patient received both scheduled doses of mRNA 1273 before the events, therefore Action taken with mRNA-1273 in response to the events was not applicable.
Very sick, chills high fever, dizzy could not stand or walk. This lasted three days.
Initial case was received from a healthcare professional on 08 April 2013. A 57-year-old male patient received a right deltoid intramuscular injection of ADACEL, sanofi pasteur Ltd., lot number C4278AA, on 27 February 2013. On 27 February 2013, same day, (also reported as starting two days after vaccination), the patient experienced pain at injection site. The patient continued to experience "insufferable pain" of entire right arm to date of report, ongoing. The patient required doctor visit. The patient's past medical history and illness at time of vaccination were not reported. Laboratory or diagnostic testing and treatments were not reported. The patient's outcome was reported as not recovered. Documents held by sender: None.
About 5 hours after initial injection. Splotchy rash/warm to touch: on wrist, elbow and below injection site on L arm.
felt a "rush" and shakiness as if I just had a cup of coffee; felt a "rush" and shakiness as if I just had a cup of coffee; felt nervous; This is a spontaneous report from a contactable consumer (patient's himself). A 56-year old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via unspecified route of administration in the left arm (Batch/Lot number unknown) on 06Mar2021 at 09:30 AM at the age of 56-year old as single dose for Covid-19 immunization and alprazolam (XANAX) 0.25 mg two hours before the vaccine (06Mar2021 at 07:30 AM) Relevant medical history included high blood pressure. Concomitant medications were not reported. The patient reported that he was very relaxed and calm and had taken less than 0.25 mg of alprazolam two hours prior. In less than two minutes after receiving the injection he felt a "rush" and shakiness as if he just had a cup of coffee. He was not short of breath and had no other symptoms. The patient tried to remain calm. The symptoms subsided in less than 30 seconds. He still felt nervous but may have been out of concern after the "rush" feeling. The site monitor approximately 8 mins. after the injection asked him how he was doing. He told him he was shaky but may have been nervous. He said he was free to leave. The patient took alprazolam that morning because he had prior Emergency Medical experience and was aware of potential anaphylaxis. The outcome of the events was recovered.  No follow-up attempts are possible. Information on Lot/batch number cannot be obtained.
Upper arm went red from the shoulder down to the elbow hot to the touch very sore at the site.  I also had numbness for 2 hours on the right side of my body.  5 days later started with a lacy type allergic reation on the RT arm.  Still having redness and pain at the sight.  Redness and a hard knot 2-3 inches around the site.
Patient reports onset approximately 3 hours after received vaccine. He had extreme difficulty breathing, chest and nasal congestion, fever of 101-102 degrees F, teeth hurt, tingling sensation on skin, chills 12-13 hours later- patient reports no fever, breathing better, some congestion remains.
presented with acute respiratory failure, COVID positive; hx of type 2 diabetes, CHF, COPD; developed acute lower extremity DVT and A Fib with RVR while in hospital; pt's condition declined; was admitted to long term care facility where he died
1 day history of fever. TYLENOL as needed every 4-6 hours. No outcomes yet.
Inadvertent Tdap was given to infant instead of DTaP. No adverse effects were reported. Patient's parent was notified and advised to return for DTaP booster.
Pt started w/crying & hi fever @ 8PM on 17JUN91; restless sleep, t104 ax went to 106 ax given APAP & used cool compresses to sore rt leg; Now using warm compresses; 18JU91 t103ax continues fussy & pulling @ ears;
I have had complete hair loss of my entire body; Complete hair loss due to the vaccine; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 24May2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization. It was reported that the patient took the second shot on 24May and patient have had complete hair loss of patient entire body, complete hair loss due to the vaccine. So now having conversation about getting a booster shot and patient not sure if patient should get a booster shot considering the side effects on the first 2. So patient guess just trying to see if there has been any studies, if anyone else has had complete hair loss due to the vaccine. The outcome of the event was unknown.  The lot number for, the vaccine, BNT162B2, was not provided and will be requested during follow up.
The patient received both COVID vaccines in the series and still contacted the COVID-19 virus. She was diagnosed via test on 5/8/2021.
Fever, headache, hoarseness, swelling of eyes and lips, hives, muscle aches, weakness, racing heart.
This case was received from a health professional in the United States on 08 May 2008, and is one of three patients reported in a cluster. A four-year-old female patient received an intramuscular left deltoid fifth injection of DAPTACEL (lot number C2950AA) and an intramuscular right deltoid fourth injection of IPOL (lot not reported) on 05 May 2008. The following day, on 06 May 2008, she returned to her doctor's office with complaints of large local left arm swelling, described as the size of a lemon. In addition, the injection site was red and warm to the touch. Treatment included BENADRYL and MOTRIN, outcome was unknown. The reporter in this case also reported two other patients with large local limb swelling following administration of DAPTACEL; those events are captured in case numbers 2008-1482 and 2008-01481.
Less than 5 minutes after receiving the vaccine I began to feel faint. Within 10 minutes of receiving the vaccine, my heart rate fell from 90+ bpm to 49 bpm, I began feeling hot, sweaty, nauseous and extremely light headed. I also acquired a headache and began uncontrollably shaking as I started to black out and struggled to remain conscious.
Patient received her Moderna Booster vaccine on 01/09/22 she stated she felt fine then at 3:00 am in the morning she woke up with numbness on her right arm and face.  She went to look in the mirror and noticed she had some drooping in her face.  She massaged the area and symptoms improved.  She reported this to pharmacy on 01/10/22 and said she is feeling better now.
Information has been received from a health professional concerning a white patient (gender not reported) who on 04-APR-2008 was vaccinated IM into the deltoid with a first dose of GARDASIL (lot # 659182/1757U). On 14-APR-2008 the patient complained of rash ("7 days after injection") to both wrists. Subsequently, the patient recovered on it's own on 18-APR-2008. No further information is available.
Patient c/o arm, chest and stomach becoming cold and tingly and areas hurt to touch. Started 3 days after PNEUMOVAX being administered.
This is a spontaneous report from a contactable health care professional (at the vaccine provider's office), through a Pfizer sales representative. The reporter's son (age and race unknown) received PREVNAR 13 on an unknown date at an unknown dose and frequency. The relevant medical history and concomitant medications were unknown. It was reported that the patient after the third dose of PREVNAR 13, experienced seizure on an unknown date. Relevant laboratory data were unknown. Therapeutic measures against the reported event were unknown. The clinical outcome of the reported event was unknown at the time of the report. Follow-up (27Apr2011): Follow-up attempts completed. No further information expected.
This spontaneous report as received from an advanced practice nurse refers to a female patient of unknown age. On 03-JUN-2013, the patient was vaccinated with the third dose of GARDASIL (route and lot # not reported) after received her first 2 doses of GARDASIL (route and lot # not reported) on unspecified dates "more than a year ago". No adverse effect was reported. Additional information has been requested.
patient is schedule to received third dose but is not immunocompromised; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (patient is schedule to received third dose but is not immunocompromised) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Flu (before the flu shot were available had frequent flus than leaded to bronchitis), Bronchitis and Pneumonia (sometimes reaching pneumonia, but is not immunocompromised). Concurrent medical conditions included Osteoporosis.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (patient is schedule to received third dose but is not immunocompromised). At the time of the report, OFF LABEL USE (patient is schedule to received third dose but is not immunocompromised) outcome was unknown.            No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter  The patient had received both doses of the Moderna vaccine, the second one was administered on 20Feb2021 and now signed up to get the third shot, the booster. Since the appointment for the third dose was schedule for 24Aug2021 and that was only 6 months and 4 days after the second dose they want to know if they should re-schedule for later.   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: follow up document contains no new information.
VOMITING AND DIARRHEA STARTED THE DAY OF THE VACCINE AND CONTINUED FOR ONE WEEK.
Tightness in breath; Heart palpitation; Pain; Troponin increased; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Tightness in breath) and PALPITATIONS (Heart palpitation) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Tightness in breath) (seriousness criterion hospitalization), PALPITATIONS (Heart palpitation) (seriousness criterion hospitalization), PAIN (Pain) and TROPONIN INCREASED (Troponin increased). At the time of the report, DYSPNOEA (Tightness in breath), PALPITATIONS (Heart palpitation), PAIN (Pain) and TROPONIN INCREASED (Troponin increased) outcome was unknown.        Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events (days after second administration), a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events (days after second administration), a causal relationship cannot be excluded.
Delayed allergic reaction on injection site . ?COVID Arm ?   Popular round lesion, edema, redness aprox 5 cms diameter.
Pt received Fluzone HD and Comirnaty 12+ from store (both in the left arm) on 9/27/2023. Pt states that she had pain during the vaccinations and believed that the vaccines were given "too high" and "in the shoulder". She stated that she has had pain radiating in the left arm ever since the vaccinations. The administering technician and the pharmacist on duty was the same person. I examined the patient's arm after she came to this pharmacy on 11/02/2023. She has a red bruise-like area along the acromion process of the left scapula. SIRVA suspected.
? Full head pressure at top, temples, crown (Exasperated by exercise/prolonged periods of talking/stress) ? Imbalance when walking accompanied by head pressure/?floaty? feeling ? Brain Fog (short-term memory, impaired focus) ? Mental/physical post exertional fatigue ? Right side head/crown nerve pain diagnosed by neurologist as occipital/trigeminal neuralgia  ? Right ear popping  ? Blood pressure swings (120/70 ?> 160/100) ? Left pectoral muscle twitching  ? Costochondritis after exercise ? Anxiety  ? Veins in both hands protrusion ? Arm, neck, leg muscle twitching ? Extremity pins/needles  ? Full body itching ? Tachycardic episodes ? Derealization episodes ? Tunnel vision/light sensitivities/visual snow/eye pressure ? Right leg numbness  ? Hand redness in both hands on palm sides ? Hand burning neuropathy on both sides
Within 10 seconds of injection tingling down to hand and then significant soreness around injection site. By 10-13 minutes still pain and thingling over forearm and down into hand. No numbness, normal strength of hand, arm and shoulder
Patient  is first responder (EMT) did not disclose  symptoms of illness at time of  vaccination or would have been denied. Reported that he developed headache and sinus issues on 12/26/2020.   Developed extreme arm soreness  in  arm  of injection site and  night-time onset of extreme chills.  Presented at  local health department  12/29/2020 9 AM for  PCR  testing and tested positive for SARS-CoV2 negative for Influenza A&B.   Chills have subsided was  of short duration - arm remains sore.  Patient  denies known route of exposure .  Was active over the  recent holiday - significant other (GF) scheduled for PCR during AM 12/30/2020  currently  asymptomatic.
I counseled patient on possible adverse effects and asked her if she had any problem with previous Moderna and she said "no." She only indicated she has bad rashes on right arm due to eczema which led to me suggesting administering on her left arm instead which she agreed. I administered into right deltoid intramuscularly, no where close to the shoulder. Patient called 2 hours later saying she is experiencing some sharp pain on her left shoulder bone and pain on the underfold skin on her left breast. She confirmed it's not chest pain, no shortness of breath. I counseled her on taking Tylenol which is her usual pain med for her pain. Go to ER if she experiences any chest pain, SOB or irregular heartbeat. Follow up with MD the next day if she continues to feel pain.
11 cm x 7 cm area of redness, swelling and itching right thigh.
About 4 hours after the vaccine, I experienced sudden nausea and abdominal pain. The symptoms lasted for about a week. They were intermittent at first. I had 3 episodes of sharp adominal pain that radiated up my back and made me short of breath. I felt pain between my shoulder blades when I tried to breathe in. The first two subsided, but the third episode on 02/16/21 was more pronounced. I felt generally unwell, like something was really wrong. I first thought it was a normal immune response or side effect. But the nausea and abdominal pain had grown worse. On 02/16/2021 I went to the ER, where a CT Scan showed I had Epiploic Appendagitis. I suspect the inflammation or a sudden ischemic event after my vaccine had caused this. I had absolutely no such symptoms prior to the vaccine, but the nausea came on exactly 4 hours after my first dose like a switch had been turned on.    In addition to the above, I experience facial flushing on the left side of my face for about 7 days after the vaccine. My forehead and right side of my face would read a normal temperature, but my left cheek averaged 101 degrees. The flushing would come on suddenly, often in the evening. I also had heart palpitations.   Other symptoms: I had the typical sore left arm for a few days. I developed joint pain on my left side, including my arm and my jaw. In general, I feel like I had a pronounced inflammatory response.
dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days; Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date) and PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date) and PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   On 25-Apr-2022 vial stored in refrigerator product BUD is 25-May-2022 No concomitant medication information provided. No treatment medication information provided.
9FEB91 @ 8P parents remembered that Pt. was fussy & felt hot. Continued to feel hot & wake up every hr through the night.
This is a spontaneous report from a contactable consumer. A 69-year-old female patient received PREVNAR 13, via an unspecified route of administration on 04Oct2018 at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced muscle pain on an unspecified date. Outcome of the event was unknown. Information on batch number has been requested.
pt recvd vax & devel a severe h/a, lightheadedness & slept most of afternoon 25FEB the same day dose 3 administered; sx treated w/APAP & rest;
Received influenza vaccine left deltoid on 11/11. New onset skin numbness left anterior knee noted 11/13. Since then have developed numbness left lower leg, today advancing across right knee and into left thigh. Reported to employee health nurse today. MD appointment pending.
w/in 24 hrs p/vax 19MAY93, pt exp arthrus react @ the inject site which included swelling, redness, hot to the touch & pruritis; pt also c/o fatigue; 21MAY93 pt is better; pt recovered;
Abdominal cramping and diarrhea pretty much beginning on day 2 post vaccination and has lasted for 10 days so far.  OTC treatment with Imodium was used.
Eight hours after the second vaccine, I felt tingling in the arms and face. My face was beet red and I couldn't breathe from the nose, my chest tightened up and I was wheezing. Only a thin stream air came out. Too tired to call an ambulance so I put cold compresses on my neck and face and took a antihistamine. Sat up like this for 4 hours. Took a blood test the following week and my eosinophils had doubled.
"massive" headache. Facial swelling w/rash. Lymphandopathy. Prednisone at tapering dose. Doxycycline.
drop in blood count; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program.  A 84 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FULL BLOOD COUNT DECREASED (non-serious), outcome "unknown", described as "drop in blood count". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient has received Covid vaccine 2.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Enlarge lymphatic tissue  Abdominal pain  Irregular/heavy/blood clotting like/painful menstrual cycle   Enlarged lymphatic tissue and abdominal pain occurred the following day.  The other symptoms occurred shortly after.  I was prescribed several medications to treat these symptoms.
Approx. 2 weeks after receiving vaccine, patient claims she becomes short of breath and her o2 sat decreases down 82 at times. patient claims that her pulse has become elevated ranging to 141 bpm. client claims prior to vaccination pulse was between 70-80bpm.
Patient states she had swollen tonsils. She immediately went to urgent care for medical attention. She states MD said it could be a reaction to the IMZ. Pt was given steroids and says she is feeling better now.